Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A New Tool to Enhance Physicians' Participation in Clinical Research.

Autor: Treviño LR; Vice president for research, DHR Health, and vice president for research operations, DHR Health Institute for Research & Development, Edinburg, Texas., Singh M; Chief executive officer, DHR Health, Edinburg, Texas., Rao S; Executive vice president, DHR Health, and president and chief executive officer, DHR Health Institute for Research & Development, Edinburg, Texas; s.rao@dhr-rgv.com .

Publikováno v: Academic medicine : journal of the Association of American Medical Colleges [Acad Med] 2022 Jul 01; Vol. 97 (7), pp. 941-942. Date of Electronic Publication: 2022 Jun 23.

Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups.

Autor: Sumazin P; Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX.; Department of Pediatrics, Baylor College of Medicine, Houston, TX.; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX., Chen Y; Departments of Epidemiology and Biostatistics, School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX., Treviño LR; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX., Sarabia SF; Pathology & Immunology, Baylor College of Medicine, Houston, TX., Hampton OA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX., Patel K; Pathology & Immunology, Baylor College of Medicine, Houston, TX., Mistretta TA; Pathology & Immunology, Baylor College of Medicine, Houston, TX., Zorman B; Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX.; Department of Pediatrics, Baylor College of Medicine, Houston, TX., Thompson P; Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX.; Department of Pediatrics, Baylor College of Medicine, Houston, TX., Heczey A; Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX.; Department of Pediatrics, Baylor College of Medicine, Houston, TX.; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX., Comerford S; Departments of Molecular Genetics and Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX., Wheeler DA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX., Chintagumpala M; Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX.; Department of Pediatrics, Baylor College of Medicine, Houston, TX.; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX., Meyers R; Department of Pediatric Surgery, University of Utah, Salt Lake City, UT., Rakheja D; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX., Finegold MJ; Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX.; Department of Pediatrics, Baylor College of Medicine, Houston, TX.; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX.; Pathology & Immunology, Baylor College of Medicine, Houston, TX., Tomlinson G; Departments of Pediatric Hematology and Oncology, School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX., Parsons DW; Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX.; Department of Pediatrics, Baylor College of Medicine, Houston, TX.; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX., López-Terrada D; Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX.; Department of Pediatrics, Baylor College of Medicine, Houston, TX.; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX.; Pathology & Immunology, Baylor College of Medicine, Houston, TX.

Publikováno v: Hepatology (Baltimore, Md.) [Hepatology] 2017 Jan; Vol. 65 (1), pp. 104-121. Date of Electronic Publication: 2016 Nov 29.

Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition.

Autor: Ramsey LB; Pharmaceutical Sciences Department, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Bruun GH, Yang W, Treviño LR, Vattathil S, Scheet P, Cheng C, Rosner GL, Giacomini KM, Fan Y, Sparreboom A, Mikkelsen TS, Corydon TJ, Pui CH, Evans WE, Relling MV

Publikováno v: Genome research [Genome Res] 2012 Jan; Vol. 22 (1), pp. 1-8. Date of Electronic Publication: 2011 Dec 06.

Human growth hormone: 45-kDa isoform with extraordinarily stable interchain disulfide links has attenuated receptor-binding and cell-proliferative activities.

Autor: Bustamante JJ; Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Kingsville, Texas 78363, USA., Grigorian AL, Muñoz J, Aguilar RM, Treviño LR, Martinez AO, Haro LS

Publikováno v: Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society [Growth Horm IGF Res] 2010 Aug; Vol. 20 (4), pp. 298-304. Date of Electronic Publication: 2010 May 15.